Table 3.
Adverse events associated with FLV and FLV+TJ-43 treatment.
| FLV | FLV+TJ-43 | ||
| Adverse events | Number (%) of patients reporting event | ||
| GI symptoms | |||
| Nausea | 9 (36) | center3 (12) | * |
| Anorexia | 3 (12) | 3 (12) | |
| Abdominal fullness | 1 (4) | 0 (0) | |
| Constipation | 1 (4) | 0 (0) | |
| Diarrhea | 1 (4) | 0 (0) | |
| Feel discomfort | 3 (12) | 2 (8) | |
| Feel irritable | 1 (4) | 0 (0) | |
| Difficulty in urinating | 1 (4) | 0 (0) | |
| General fatigue | 1 (4) | 0 (0) | |
| Tremor | 0 (0) | 1 (4) | |
| /25 | /25 | ||
FLV = fluvoxamine; TJ-43 = Rikkunshito; GI:gastrointestinal. * p < 0.05 by Fisher exact probability test.